PT Suparma Tbk (IDX:SPMA)
Indonesia · Delayed Price · Currency is IDR 228.00
-2.00 (-0.87%)
At close: Feb 27, 2026
PT Suparma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,757,750 | 2,729,636 | 2,658,521 | 3,138,054 | 2,794,453 | 2,151,495 | |
Revenue Growth (YoY) | 3.36% | 2.67% | -15.28% | 12.30% | 29.88% | -14.42% |
Cost of Revenue | 2,360,465 | 2,324,167 | 2,196,750 | 2,427,849 | 2,212,061 | 1,765,848 |
Gross Profit | 397,286 | 405,469 | 461,771 | 710,205 | 582,392 | 385,647 |
Selling, General & Admin | 218,069 | 209,905 | 206,708 | 183,723 | 169,709 | 154,023 |
Other Operating Expenses | 9,654 | 5,228 | - | 613.51 | - | 2,560 |
Operating Expenses | 227,723 | 215,133 | 206,708 | 184,337 | 169,709 | 156,583 |
Operating Income | 169,562 | 190,336 | 255,063 | 525,868 | 412,683 | 229,064 |
Interest Expense | -36,950 | -35,208 | -34,876 | -32,682 | -31,355 | -33,558 |
Interest & Investment Income | 7,185 | 7,541 | 5,809 | 4,247 | 1,344 | 2,783 |
Currency Exchange Gain (Loss) | -60,228 | -29,452 | 9,086 | -65,997 | 335.94 | -2,217 |
Other Non Operating Income (Expenses) | -3,724 | -3,424 | 3,042 | 632.25 | 3,373 | -568.22 |
EBT Excluding Unusual Items | 75,845 | 129,793 | 238,124 | 432,068 | 386,381 | 195,503 |
Gain (Loss) on Sale of Investments | 853.55 | 4,650 | -461.94 | -622.47 | - | - |
Gain (Loss) on Sale of Assets | - | - | 186.72 | - | - | - |
Other Unusual Items | - | - | - | - | -8,871 | - |
Pretax Income | 76,699 | 134,443 | 237,849 | 431,446 | 377,510 | 195,503 |
Income Tax Expense | 18,303 | 29,604 | 59,190 | 95,308 | 83,184 | 32,979 |
Net Income | 58,396 | 104,839 | 178,658 | 336,138 | 294,326 | 162,525 |
Net Income to Common | 58,396 | 104,839 | 178,658 | 336,138 | 294,326 | 162,525 |
Net Income Growth | -61.02% | -41.32% | -46.85% | 14.21% | 81.10% | 24.06% |
Shares Outstanding (Basic) | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 |
Shares Outstanding (Diluted) | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 | 4,100 |
EPS (Basic) | 14.24 | 25.57 | 43.57 | 81.98 | 71.78 | 39.64 |
EPS (Diluted) | 14.24 | 25.57 | 43.57 | 81.98 | 71.78 | 39.64 |
EPS Growth | -61.02% | -41.32% | -46.85% | 14.21% | 81.10% | 24.06% |
Free Cash Flow | 629,974 | 671,488 | 654,950 | 862,153 | 744,770 | 640,090 |
Free Cash Flow Per Share | 153.64 | 163.76 | 159.73 | 210.26 | 181.64 | 156.11 |
Dividend Per Share | - | - | 9.231 | - | - | 7.736 |
Gross Margin | 14.41% | 14.85% | 17.37% | 22.63% | 20.84% | 17.93% |
Operating Margin | 6.15% | 6.97% | 9.59% | 16.76% | 14.77% | 10.65% |
Profit Margin | 2.12% | 3.84% | 6.72% | 10.71% | 10.53% | 7.55% |
Free Cash Flow Margin | 22.84% | 24.60% | 24.64% | 27.47% | 26.65% | 29.75% |
EBITDA | 306,888 | 299,377 | 352,014 | 616,613 | 493,098 | 322,469 |
EBITDA Margin | 11.13% | 10.97% | 13.24% | 19.65% | 17.65% | 14.99% |
D&A For EBITDA | 137,326 | 109,041 | 96,951 | 90,745 | 80,415 | 93,406 |
EBIT | 169,562 | 190,336 | 255,063 | 525,868 | 412,683 | 229,064 |
EBIT Margin | 6.15% | 6.97% | 9.59% | 16.76% | 14.77% | 10.65% |
Effective Tax Rate | 23.86% | 22.02% | 24.89% | 22.09% | 22.04% | 16.87% |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.